TLDR A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.
The study developed a method to determine steroid 5α-reductase activity using liquid chromatography/atmospheric pressure chemical ionization–mass spectrometry (LC/APCI-MS) in positive-ion mode. The method utilized a rat prostatic enzyme source to measure the enzymatic formation of 5α-dihydrotestosterone and 5α-androstane-3α,17β-diol, with the sum of these products indicating enzyme activity. This approach was applied to kinetic studies and inhibitory experiments using Finasteride® as a model inhibitor, providing a means to assess the enzyme's activity and inhibition.
184 citations
,
January 2000 in “European Urology” Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.
17 citations
,
June 1996 in “The Journal of Steroid Biochemistry and Molecular Biology” FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.
193 citations
,
August 1985 in “Endocrinology” Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.
46 citations
,
September 2011 in “Journal of Endocrinology” Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.
41 citations
,
March 1998 in “Archives of Dermatological Research” The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.
61 citations
,
December 2001 in “Journal of Investigative Dermatology” Steroid sulfatase in hair follicles may be a target for treating hair loss.
56 citations
,
November 2007 in “Molecular and cellular endocrinology” Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.
196 citations
,
May 2001 in “The journal of investigative dermatology/Journal of investigative dermatology” Sebocytes play a key role in controlling androgen levels in human skin.